These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9247891)

  • 1. Cure or control of HIV/AIDS?
    Collins DO; Sakamoto A
    Med Hypotheses; 1997 Jun; 48(6):489-90. PubMed ID: 9247891
    [No Abstract]   [Full Text] [Related]  

  • 2. [HIV: to administer protease inhibitors early].
    Dtsch Med Wochenschr; 1996 Dec; 121(49):A49. PubMed ID: 8998916
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiretroviral therapy: a guide to the most important trials.
    Rutschmann O; Hirschel B
    Schweiz Med Wochenschr; 1997 Mar; 127(11):436-43. PubMed ID: 9098917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nipping HIV in the bud.
    Smart T
    GMHC Treat Issues; 1996 Aug; 10(8):3-6. PubMed ID: 11363719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
    Paris D; Ledergerber B; Weber R; Jost J; Flepp M; Opravil M; Ruef C; Zimmerli S
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1631-8. PubMed ID: 10606086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Meeting of the Pediatric Work Group AIDS in Germany (PAAD) on May 8-9, 1998 in Frankfurt/Main].
    Funk M
    Klin Padiatr; 1999; 211(2):96-7. PubMed ID: 10407820
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
    García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
    AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crixivan reduces viral load.
    AIDS Patient Care STDS; 1996 Feb; 10(1):50. PubMed ID: 11361665
    [No Abstract]   [Full Text] [Related]  

  • 9. A patient's guide to protease inhibitors.
    Elperin A; Sax P
    AIDS Clin Care; 1996 Oct; 8(10):83-4. PubMed ID: 11363988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraindicated antiretroviral drug combinations.
    Macher A; Thomas D; Paul SM
    N J Med; 2003 Sep; 100(9 Suppl):41-3; quiz 73-4. PubMed ID: 14556602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease inhibitors and prevention of cross resistance.
    Levin J
    AIDS Treat News; 1995 Oct; (no 232):1-3. PubMed ID: 11362875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of two different triple drug combinations in which either lamivudine or didanosine were administered with stavudine plus indinavir.
    Villalba N; Gómez-Cano M; Casas E; Soriano V; Valencia E; González-Lahoz J
    AIDS; 1997 Dec; 11(15):1896-7. PubMed ID: 9412717
    [No Abstract]   [Full Text] [Related]  

  • 13. Guide to major clinical trials of antiretroviral therapy administered to patients infected with human immunodeficiency virus.
    Spooner KM; Lane HC; Masur H
    Clin Infect Dis; 1996 Jul; 23(1):15-27. PubMed ID: 8816123
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nevirapine: a new principle of action against HIV].
    Dtsch Med Wochenschr; 1996 Dec; 121(49):A48-9. PubMed ID: 8998915
    [No Abstract]   [Full Text] [Related]  

  • 15. Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence. HIV Trialists' Collaborative Group.
    Lancet; 1999 Jun; 353(9169):2014-25. PubMed ID: 10376616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral effect of AZT versus stavudine in combination with lamivudine and indinavir in the context of a populational study.
    Jahnke N; Yip B; Hogg RS; O'Shaughnessy M; Montaner JS
    J Acquir Immune Defic Syndr; 1999 Aug; 21(4):347-8. PubMed ID: 10428115
    [No Abstract]   [Full Text] [Related]  

  • 17. Stavudine, lamivudine and indinavir in children with advanced HIV-1 infection: preliminary experience.
    Monpoux F; Sirvent N; Cottalorda J; Mariani R; Lefbvre JC
    AIDS; 1997 Oct; 11(12):1523-5. PubMed ID: 9342078
    [No Abstract]   [Full Text] [Related]  

  • 18. Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS clinical trials group 229.
    Schapiro JM; Lawrence J; Speck R; Winters MA; Efron B; Coombs RW; Collier AC; Merigan TC
    J Infect Dis; 1999 Jan; 179(1):249-53. PubMed ID: 9841849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of AIDS treatment with two nucleoside analogues alone.
    Weidle PJ; Mbidde E; Djomand G; Lackritz EM
    Lancet; 1999 Jun; 353(9169):1989-90. PubMed ID: 10376610
    [No Abstract]   [Full Text] [Related]  

  • 20. Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.
    Gerstoft J; Kirk O; Obel N; Pedersen C; Mathiesen L; Nielsen H; Katzenstein TL; Lundgren JD
    AIDS; 2003 Sep; 17(14):2045-52. PubMed ID: 14502007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.